Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rifkin

Showing results (101-110 of 329) with videos related to

Pageof 33
Sort By:
Cancer Research|February 1, 1996
Effects of endogenously activated transforming growth factor-beta on growth and differentiation of retinoic acid-treated HL-60 cellsI Nunes, S Kojima, D B Rifkin
The Journal of Cell Biology|April 1, 1993
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cellsS Kojima, K Nara, D B Rifkin
Journal of Biochemistry|August 28, 2012
Matrix control of transforming growth factor-β functionMasahito Horiguchi, Mitsuhiko Ota, Daniel B Rifkin
Journal of Cellular Physiology|May 1, 1991
The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signalN Quarto, F P Finger, D B Rifkin
Virology|August 1, 1975
The organization of the proteins of vesicular stomatitis virions: labeling with pyridoxal phosphateR Eger, R W Compans, D B Rifkin
Archives of Public Health = Archives Belges De Sante Publique|January 22, 2022
Has Latin America achieved universal health coverage yet? Lessons from four countriesRamiro E Gilardino, Pilar Valanzasca, Susan B Rifkin
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Characterization of latent TGF-beta activation by murine peritoneal macrophagesI Nunes, R L Shapiro, D B Rifkin
Progress in Clinical and Biological Research|January 1, 1985
Purification and characterization of a low molecular mass cysteine proteinase inhibitor from human amniotic fluidS T Rohrlich, H Levy, D B Rifkin
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2000
Measurement of active TGF-beta generated by cultured cellsR Mazzieri, J S Munger, D B Rifkin
Biological Chemistry Hoppe-Seyler|February 1, 1985
Purification and characterization of a low molecular mass cysteine proteinase inhibitor from human amniotic fluidS T Rohrlich, H Levy, D B Rifkin
Pageof 33

Showing results (101-110 of 329) with videos related to

Sort By:
Pageof 33
Cancer Research|February 1, 1996
Effects of endogenously activated transforming growth factor-beta on growth and differentiation of retinoic acid-treated HL-60 cellsI Nunes, S Kojima, D B Rifkin
The Journal of Cell Biology|April 1, 1993
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cellsS Kojima, K Nara, D B Rifkin
Journal of Biochemistry|August 28, 2012
Matrix control of transforming growth factor-β functionMasahito Horiguchi, Mitsuhiko Ota, Daniel B Rifkin
Journal of Cellular Physiology|May 1, 1991
The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signalN Quarto, F P Finger, D B Rifkin
Virology|August 1, 1975
The organization of the proteins of vesicular stomatitis virions: labeling with pyridoxal phosphateR Eger, R W Compans, D B Rifkin
Archives of Public Health = Archives Belges De Sante Publique|January 22, 2022
Has Latin America achieved universal health coverage yet? Lessons from four countriesRamiro E Gilardino, Pilar Valanzasca, Susan B Rifkin
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Characterization of latent TGF-beta activation by murine peritoneal macrophagesI Nunes, R L Shapiro, D B Rifkin
Progress in Clinical and Biological Research|January 1, 1985
Purification and characterization of a low molecular mass cysteine proteinase inhibitor from human amniotic fluidS T Rohrlich, H Levy, D B Rifkin
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2000
Measurement of active TGF-beta generated by cultured cellsR Mazzieri, J S Munger, D B Rifkin
Biological Chemistry Hoppe-Seyler|February 1, 1985
Purification and characterization of a low molecular mass cysteine proteinase inhibitor from human amniotic fluidS T Rohrlich, H Levy, D B Rifkin
Pageof 33